DeepMed Research

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer

Phase 2

Completed

Conditions: Carcinoma, Squamous Cell

Interventions: Procedure: FDG-PET/CT
Drug: Cetuximab

First Posted Date: 2008-05-05

Last Posted Date: 2017-03-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 42

Registration Number: NCT00671437

Locations: 🇺🇸
University of Louisville, Louisville, Kentucky, United States
🇺🇸
Washington University, St. Louis, Missouri, United States

Evaluating a Blood Pressure Reduction and Weight Loss Program in a Low Income, Ethnically Diverse Population (The Be Fit, Be Well [BFBW] Study)

Not Applicable

Completed

Conditions: Hypertension
Obesity

Interventions: Behavioral: Usual Care and Reading Materials
Behavioral: Lifestyle Modification Program

First Posted Date: 2008-04-18

Last Posted Date: 2012-03-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 365

Registration Number: NCT00661817

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer

Phase 2

Completed

Conditions: Cholangiocarcinoma
Gallbladder Cancer

Interventions: Drug: Gemcitabine
Drug: Carboplatin

First Posted Date: 2008-04-17

Last Posted Date: 2013-08-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 49

Registration Number: NCT00660140

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors

Phase 1

Completed

Conditions: Advanced Gastrointestinal Malignancies
Solid Tumors

Interventions: Drug: Oxaliplatin
Drug: Gemcitabine
Drug: Capecitabine

First Posted Date: 2008-04-17

Last Posted Date: 2013-04-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT00660426

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Chemotherapy and Radiation Following Pancreatic Surgery

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Procedure: Pancreatic Surgery
Radiation: Radiation therapy
Drug: Cisplatin
Drug: 5-FU
Drug: Alpha-interferon
Drug: Gemcitabine

First Posted Date: 2008-04-17

Last Posted Date: 2013-04-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 53

Registration Number: NCT00660270

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

Phase 2

Completed

Conditions: Gallbladder Cancer
Cholangiocarcinoma Cancer
Ampullary Cancer
Pancreatic Cancer

Interventions: Drug: Gemcitabine
Drug: Docetaxel
Radiation: Radiation

First Posted Date: 2008-04-17

Last Posted Date: 2015-05-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT00660699

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Vitamins in Nitrous Oxide Study

Not Applicable

Completed

Conditions: Major Surgery
Coronary Artery Disease

Interventions: Drug: Vitamin B12 and folic acid
Drug: Nitrous oxide and placebo
Other: standard of care

First Posted Date: 2008-04-10

Last Posted Date: 2020-10-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 687

Registration Number: NCT00655980

Locations: 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)

Phase 1

Completed

Conditions: Tourette Syndrome

Interventions: Drug: placebo
Drug: levodopa solution 2mg/ml for i.v. use

First Posted Date: 2008-03-13

Last Posted Date: 2018-02-12

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 49

Registration Number: NCT00634556

Locations: 🇺🇸
Washington Universisty School of Medicine,, Saint Louis, Missouri, United States

The Role of Cerebral Hemodynamics in Moyamoya Disease

Completed

Conditions: Moyamoya
Stroke

First Posted Date: 2008-03-06

Last Posted Date: 2018-05-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 56

Registration Number: NCT00629915

Locations: 🇺🇸
Washington University School Of Medicine, 510 South Kingshighway Blvd, Saint Louis, Missouri, United States

Yoga for the Management of HIV-Metabolic Syndromes

Phase 4

Completed

Conditions: HIV Infections
HIV Metabolic Cardiovascular Syndrome
HIV Lipodystrophy
HIV Metabolic Syndromes
Hypertension

Interventions: Other: Standard of care
Behavioral: Yoga lifestyle intervention

First Posted Date: 2008-03-03

Last Posted Date: 2010-07-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 60

Registration Number: NCT00627380

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy